IMO In another 2 years I see a company with a phase 3 HSV and phase 2 in HPV and possibly another phase 1b in something else, a revenue that hopefully will be positive. All this for todays market cap of < 120M. Yes i think there will be more cap raises but i think the team want to go as far as they can by themselves before a partner. Every week we progress past completion of phase 2 the upfront from a pharma must be larger. I think i recall the professor saying he was wanting to develop something from lab to bedside. ( i hope i recall correctly). I wonder how close to the bedside can we get by ourselves. This was always going to be a long play.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
IMO In another 2 years I see a company with a phase 3 HSV and...
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.55 |
Change
-0.130(1.11%) |
Mkt cap ! $244.1M |
Open | High | Low | Value | Volume |
$11.71 | $11.89 | $11.41 | $703.3K | 60.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $11.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.83 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 11.550 |
1 | 1341 | 11.500 |
1 | 1000 | 11.400 |
1 | 2 | 11.260 |
1 | 8 | 11.220 |
Price($) | Vol. | No. |
---|---|---|
11.830 | 500 | 1 |
11.900 | 1000 | 1 |
12.000 | 5317 | 2 |
12.400 | 198 | 1 |
12.500 | 429 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |